Table 1 Baseline characteristics of patients
Characteristics | Total (n = 400) |
|---|---|
n (%) | |
Age | |
  > 50 ys | 265 (66%) |
  < 50 ys | 135 (34%) |
BMI | |
  > 30 | 144 (36%) |
  < 30 | 256 (64%) |
Race | |
 White | 331 (83%) |
 African American | 48 (12%) |
 Other | 21 (5%) |
Tumor size | |
  < 2 cm | 175 (44%) |
  > 2 cm | 225 (56%) |
Nodal Status | |
 N0 | 214 (54%) |
 N+ | 186 (47%) |
ER Positive | |
 Yes | 255 (64%) |
 No | 145 (36%) |
Grade | |
 I | 15 (4%) |
 II | 137 (34%) |
 III | 245 (61%) |
 Missing | 3 (1%) |
Pre-existing Cardiovascular risk factors | |
 Smoking | 124 (31%) |
 Hyperlipidemia | 133 (33%) |
 Hypertension | 71 (18%) |
 Diabetes Mellitus | 46 (12%) |
 Heart Failure | 8 (2%) |
 Ischemic Heart Disease | 20 (5%) |
 Arrhythmias | 21 (5%) |
 Valvular diseases | 20 (5%) |
Adjuvant Systemic Therapy | |
 Trastuzumab | |
  Yes | 369 (92%) |
  No | 31 (8%) |
 Chemotherapy | |
  Anthracyclines | 212 (53%) |
  Non-Anthracyclines | 153 (38%) |
  No chemotherapy | 35 (9%) |
 Hormonal Therapy | |
  Yes | 250 (63%) |
  No | 150 (37%) |